🇺🇸 FDA
Pipeline program

UX-GIP001

UX-GIP001-102

Phase 1 small_molecule active

Quick answer

UX-GIP001 for Epilepsy is a Phase 1 program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Epilepsy
Phase
Phase 1
Modality
small_molecule
Status
active

Clinical trials